Follow
Alicia Ponte Sucre
Title
Cited by
Cited by
Year
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
A Ponte-Sucre, F Gamarro, JC Dujardin, MP Barrett, R López-Vélez, ...
PLoS neglected tropical diseases 11 (12), e0006052, 2017
7482017
Leishmania spp.: proficiency of drug-resistant parasites
S Natera, C Machuca, M Padrón-Nieves, A Romero, E Díaz, ...
International journal of antimicrobial agents 29 (6), 637-642, 2007
1512007
Activities of Naphthylisoquinoline Alkaloids and Synthetic Analogs against Leishmania major
A Ponte-Sucre, JH Faber, T Gulder, I Kajahn, SEH Pedersen, ...
Antimicrobial agents and chemotherapy 51 (1), 188-194, 2007
1142007
Ancistrocladinium A and B, the First N,C-Coupled Naphthyldihydroisoquinoline Alkaloids, from a Congolese Ancistrocladus Species
G Bringmann, I Kajahn, M Reichert, SEH Pedersen, JH Faber, T Gulder, ...
The Journal of Organic Chemistry 71 (25), 9348-9356, 2006
1112006
Aziridine-2, 3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents
R Vicik, V Hoerr, M Glaser, M Schultheis, E Hansell, JH McKerrow, ...
Bioorganic & medicinal chemistry letters 16 (10), 2753-2757, 2006
1112006
An overview of Trypanosoma brucei infections: an intense host–parasite interaction
A Ponte-Sucre
Frontiers in microbiology 7, 232783, 2016
952016
Aziridine-2, 3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity
A Ponte-Sucre, R Vicik, M Schultheis, T Schirmeister, H Moll
Antimicrobial agents and chemotherapy 50 (7), 2439-2447, 2006
952006
Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?
M Vanaerschot, F Dumetz, S Roy, A Ponte-Sucre, J Arevalo, JC Dujardin
Expert review of anti-infective therapy 12 (8), 937-946, 2014
872014
Physiological consequences of drug resistance in Leishmaniaand their relevance for chemotherapy
A Ponte-Sucre
Kinetoplastid Biology and Disease 2, 1-10, 2003
812003
Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells
A Ponte‐Sucre, D Heise, H Moll
Immunology 104 (4), 462-467, 2001
692001
Availability and applications of ATP-binding cassette (ABC) transporter blockers
A Ponte-Sucre
Applied microbiology and biotechnology 76 (2), 279-286, 2007
622007
Structure−Activity Relationship and Studies on the Molecular Mechanism of Leishmanicidal N,C-Coupled Arylisoquinolinium Salts
A Ponte-Sucre, T Gulder, A Wegehaupt, C Albert, C Rikanovic, ...
Journal of medicinal chemistry 52 (3), 626-636, 2009
592009
Do we need new drugs against human African trypanosomiasis?
A Stich, A Ponte-Sucre, U Holzgrabe
The Lancet Infectious Diseases 13 (9), 733-734, 2013
452013
Antitrypanosomal activity of quaternary naphthalimide derivatives
M Muth, V Hoerr, M Glaser, A Ponte-Sucre, H Moll, A Stich, U Holzgrabe
Bioorganic & medicinal chemistry letters 17 (6), 1590-1593, 2007
452007
Leishmania sp.: growth and survival are impaired by ion channel blockers
A Ponte-Sucre, Y Campos, M Fernandez, H Moll, A Mendoza-León
Experimental Parasitology 88 (1), 11-19, 1998
451998
Drug resistance in Leishmania parasites
A Ponte-Sucre, E Diaz, M Padrón-Nieves
Cham: Springer, 2013
442013
Novel lead compounds in pre-clinical development against African sleeping sickness
M Berninger, I Schmidt, A Ponte-Sucre, U Holzgrabe
MedChemComm 8 (10), 1872-1890, 2017
392017
Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro
CR Caffrey, D Steverding, RK Swenerton, B Kelly, D Walshe, A Debnath, ...
Antimicrobial agents and chemotherapy 51 (6), 2164-2172, 2007
382007
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus
T Goebel, D Ulmer, H Projahn, J Kloeckner, E Heller, M Glaser, ...
Journal of medicinal chemistry 51 (2), 238-250, 2008
352008
ABC transporters in microorganisms: research, innovation and value as targets against drug resistance
A Ponte-Sucre
Caister Academic, 2009
342009
The system can't perform the operation now. Try again later.
Articles 1–20